Dr. Guilda Sarraf, M.D

NPI: 1396928586
Total Payments
$1,095
2024 Payments
$249.80
Companies
8
Transactions
15
Medicare Patients
3,854
Medicare Billing
$541,262

Payment Breakdown by Category

Food & Beverage$1,073 (98.0%)
Education$21.73 (2.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,073 14 98.0%
Education $21.73 1 2.0%

Top Paying Companies

Company Total Records Latest Year
Amgen Inc. $439.78 4 $0 (2019)
Janssen Pharmaceuticals, Inc $198.59 4 $0 (2023)
Novartis Pharmaceuticals Corporation $137.14 2 $0 (2022)
AstraZeneca Pharmaceuticals LP $125.00 1 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $124.80 1 $0 (2024)
HeartFlow, Inc. $29.50 1 $0 (2019)
Regeneron Healthcare Solutions, Inc. $21.73 1 $0 (2022)
Arbor Pharmaceuticals, Inc. $18.07 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $249.80 2 AstraZeneca Pharmaceuticals LP ($125.00)
2023 $149.99 1 Janssen Pharmaceuticals, Inc ($149.99)
2022 $35.86 2 Regeneron Healthcare Solutions, Inc. ($21.73)
2020 $11.54 1 Janssen Pharmaceuticals, Inc ($11.54)
2019 $240.07 3 Novartis Pharmaceuticals Corporation ($123.01)
2018 $124.58 2 Amgen Inc. ($105.11)
2017 $282.77 4 Amgen Inc. ($247.11)

All Payment Transactions

15 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
06/20/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $124.80 General
Category: DIABETES
03/07/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular and Metabolism
11/08/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $149.99 General
Category: Cardiovascular & Metabolism
05/13/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $14.13 General
Category: CARDIOVASCULAR
01/20/2022 Regeneron Healthcare Solutions, Inc. EVKEEZA (Biological) Education In-kind items and services $21.73 General
Category: CARDIOVASCULAR AND METABOLISM
03/02/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $11.54 General
Category: Cardiovascular & Metabolism
11/14/2019 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $87.56 General
Category: Cardiology
09/17/2019 HeartFlow, Inc. Food and Beverage Cash or cash equivalent $29.50 General
05/23/2019 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $123.01 General
Category: CARDIOVASCULAR
07/18/2018 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $105.11 General
Category: Cardiology
01/31/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.47 General
Category: Cardiovascular & Metabolism
12/05/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.59 General
Category: Cardiovascular & Metabolism
11/01/2017 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $122.31 General
Category: Cardiology
08/08/2017 Arbor Pharmaceuticals, Inc. Edarbi (Drug) Food and Beverage Cash or cash equivalent $18.07 General
Category: Cardiology/Vascular Diseases
04/18/2017 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $124.80 General
Category: Cardiology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 1,121 1,691 $301,510 $143,478
2022 7 1,065 1,750 $314,610 $156,744
2021 8 943 1,619 $281,145 $142,298
2020 8 725 1,274 $215,880 $98,742
Total Patients
3,854
Total Services
6,334
Medicare Billing
$541,262
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 273 605 $96,735 $60,797 62.8%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2023 215 218 $87,200 $36,520 41.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 207 264 $23,760 $18,172 76.5%
93351 Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report Office 2023 71 71 $33,725 $14,721 43.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 60 60 $22,500 $8,019 35.6%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 233 360 $34,200 $4,300 12.6%
36415 Insertion of needle into vein for collection of blood sample Office 2023 62 113 $3,390 $949.20 28.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 253 684 $109,655 $72,329 66.0%
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function Office 2022 205 209 $83,600 $37,041 44.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 193 248 $22,320 $17,436 78.1%
93351 Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report Office 2022 77 77 $36,575 $15,987 43.7%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 76 76 $28,500 $9,720 34.1%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 196 312 $29,640 $3,803 12.8%
36415 Insertion of needle into vein for collection of blood sample Office 2022 65 144 $4,320 $427.89 9.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 214 630 $100,800 $67,307 66.8%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Office 2021 172 174 $69,600 $31,096 44.7%
93351 Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report Office 2021 74 74 $35,150 $15,965 45.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 166 208 $18,720 $14,595 78.0%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 57 57 $21,375 $7,638 35.7%
93000 Routine ekg using at least 12 leads including interpretation and report Office 2021 168 284 $26,980 $3,611 13.4%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 15 23 $3,450 $1,579 45.8%
36415 Insertion of needle into vein for collection of blood sample Office 2021 77 169 $5,070 $507.00 10.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 168 509 $81,440 $44,477 54.6%
93306 Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Office 2020 123 124 $49,600 $23,105 46.6%
93351 Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report Office 2020 44 45 $21,375 $9,171 42.9%

About Dr. Guilda Sarraf, M.D

Dr. Guilda Sarraf, M.D is a Specialist healthcare provider based in Torrance, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396928586.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Guilda Sarraf, M.D has received a total of $1,095 in payments from pharmaceutical and medical device companies, with $249.80 received in 2024. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,073).

As a Medicare-enrolled provider, Sarraf has provided services to 3,854 Medicare beneficiaries, totaling 6,334 services with total Medicare billing of $541,262. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.

Practice Information

  • Specialty Specialist
  • Location Torrance, CA
  • Active Since 12/11/2007
  • Last Updated 08/30/2013
  • Taxonomy Code 174400000X
  • Entity Type Individual
  • NPI Number 1396928586

Products in Payments

  • Repatha (Biological) $439.78
  • XARELTO (Drug) $198.59
  • ENTRESTO (Drug) $137.14
  • FARXIGA (Drug) $125.00
  • JARDIANCE (Drug) $124.80
  • EVKEEZA (Biological) $21.73
  • Edarbi (Drug) $18.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Specialist Doctors in Torrance